Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
31,493,925
-
Share change
-
+3,086,063
-
Total reported value
-
$3,210,703,884
-
Put/Call ratio
-
94%
-
Price per share
-
$101.96
-
Number of holders
-
211
-
Value change
-
+$331,269,481
-
Number of buys
-
111
-
Number of sells
-
93
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2023
As of 30 Jun 2023,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
211 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,493,925 shares.
The largest 10 holders included
CPMG Inc, VANGUARD GROUP INC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., DEUTSCHE BANK AG\, WELLINGTON MANAGEMENT GROUP LLP, First Light Asset Management, LLC, Boxer Capital, LLC, JANUS HENDERSON GROUP PLC, and STATE STREET CORP.
This page lists
211
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.